Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:38 pm Purchase |
2024-12-31 | 13G | Upstream Bio, Inc. UPB |
Decheng Capital Global Life Sciences Fund IV, L.P. | 3,285,293 6.100% |
3,285,293 (New Position) |
Filing History |
| 2025-02-14 4:23 pm Purchase |
2024-12-31 | 13G | Upstream Bio, Inc. UPB |
TCG Crossover GP I, LLC | 2,801,763 5.200% |
2,801,763 (New Position) |
Filing History |
| 2025-02-13 4:16 pm Purchase |
2024-12-31 | 13G | Upstream Bio, Inc. UPB |
HBM BIOVENTURES CAYMAN LTD | 2,715,056 5.100% |
2,715,056 (New Position) |
Filing History |
| 2025-02-12 09:34 am Purchase |
2024-12-31 | 13G | Upstream Bio, Inc. UPB |
FMR CORP | 7,176,187 13.400% |
1,106,311 (+18.23%) |
Filing History |
| 2024-11-07 09:24 am Purchase |
2024-11-06 | 13G | Upstream Bio, Inc. UPB |
FMR CORP | 6,069,876 11.822% |
6,069,876 (New Position) |
Filing History |
| 2024-10-22 4:06 pm Purchase |
2024-10-15 | 13D | Upstream Bio, Inc. UPB |
AI Upstream LLC | 5,494,410 10.700% |
5,494,410 (New Position) |
Filing History |
| 2024-10-18 6:10 pm Purchase |
2024-10-15 | 13G | Upstream Bio, Inc. UPB |
BCLS Fund III Investments, LP | 2,295,322 4.300% |
2,295,322 (New Position) |
Filing History |
| 2024-10-17 4:16 pm Purchase |
2024-10-15 | 13D | Upstream Bio, Inc. UPB |
ORBIMED ADVISORS LLC | 4,554,873 8.900% |
4,554,873 (New Position) |
Filing History |